Company Filing History:
1 out of 3,539 
1 out of 1,168 
1 out of 832,880 Years Active: 2010-2012
Title: The Innovative Contributions of Inventor Daniel Schindler
Introduction: Daniel Schindler, an influential inventor based in Rehovot, Israel, has made significant strides in the field of biotechnology. With two notable patents to his name, his work focuses on advancing therapeutic treatments through the development of chimeric receptor genes and transformed lymphocytes.
Latest Patents: Schindler's latest patents revolve around the creation of chimeric receptor genes that endow lymphocytes with antibody-type specificity. These innovative genes consist of a first gene segment encoding a single-chain Fv domain of a specific antibody, along with a second gene segment that includes all or part of the transmembrane and cytoplasmic domains. This design allows the chimeric receptor gene, when transfected into immune cells, to express an antibody-recognition site and the immune cell-triggering moiety as a single continuous chain. The transformed lymphocytes are particularly useful in various therapeutic treatment methods.
Career Highlights: Throughout his career, Daniel Schindler has contributed to some remarkable advancements in immunology. His innovative research has garnered attention for its potential applications in therapeutic settings, particularly for enhancing the specificity and effectiveness of immune responses in patients.
Collaborations: Schindler has collaborated with esteemed professionals such as Zelig Eshhar and Tova Waks, enriching his research efforts with their expertise. In addition, he has worked with established organizations, including the Government of the United States of America as represented by the Secretary of the Department of Health and Human Services.
Conclusion: Daniel Schindler exemplifies the spirit of innovation within the biotechnology sector. His patents and collaborative efforts underscore the importance of interdisciplinary teamwork in addressing complex medical challenges. As his work continues to evolve, it holds great promise for future therapeutic advancements.